NEW YORK (GenomeWeb) – Sequenom Chief Medical Officer Allan Bombard plans to retire in June, the company said in a filing with the US Securities and Exchange Commission this week. Bombard has served as the firm's CMO since early 2009, and as one of its CLIA/CAP lab directors since 2010.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.